NCT02129751: Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder |
|
|
| Not yet recruiting | 4 | 200 | US | bupropion hydrobromide, Aplenzin, Placebo | Bausch Health Americas, Inc. | Major Depressive Disorder | 11/24 | 11/24 | | |
